英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • KERENDIA® (finerenone) | Treatment for Adults with CKD in T2D . . .
    Learn about KERENDIA® (finerenone), a medication for chronic kidney disease in adults with T2D and heart failure with LVEF ≥40% See safety and full prescribing info
  • Diabetes Management in Chronic Kidney Disease: A Consensus . . .
    A rapidly expanding number of clinical trials are advancing clinical care in the field of diabetes and chronic kidney disease (CKD) The American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) each follow structured processes to assess these data and develop rigorous, evidence-based guidelines for adults with diabetes and CKD (1, 2) Areas of consensus between
  • 2026 Diabetes Treatment Guidelines Update: ADA vs NICE
    6 Cardiovascular Risk and Comorbidity Management Blood Pressure Both Guidelines Individualise BP targets ACE inhibitor or ARB recommended in patients with albuminuria or CKD General target for most adults with T2D: below 130 80 mmHg ADA 2026 Systolic BP below 120 mmHg is now encouraged for individuals at high cardiovascular or kidney risk For older frail adults, a relaxed target of below
  • The foundation and the four pillars of treatment for . . .
    Of the 8 billion people who share this planet, it is estimated that one in eight have chronic kidney disease (CKD) The prevalence of type 2 diabetes (T2D) is also estimated to be one in eight According to the Centers for Disease Control, one in three people with T2D have CKD CKD and T2D collaborate to increase the risk of all-cause mortality, cardiovascular mortality, cardiovascular
  • ACE Inhibitor or ARB Treatment Among Patients With . . . - AJMC
    OBJECTIVES: Many patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) experience a delay in treatment or fail to initiate treatment with guideline-recommended angiotensin
  • Working Your Way through ADA’s T2D Treatment Algorithm
    Working Your Way through ADA’s T2D Treatment Algorithm Jennifer B Marks, MD, FACP, FACE Professor Emerita University of Miami Miller School of Medicine
  • Guidelines in T2D| JARDIANCE
    CV risk for patients with T2D, HF, and or CKD6-15 The interconnectivity of cardio, renal, and metabolic diseases amplifies and accelerates risk16, as evidenced by the latest treatment guidelines that emphasize the importance of reducing the risk of CV events and or disease progression in patients with T2D, HF, and or CKD 6-15
  • Forxiga (dapagliflozin) for Treatment of Type 2 Diabetes
    It is approved for the treatment of HF and CKD in adult patients in more than 100 countries worldwide In June 2024, the FDA extended the drug label to improve glycaemic control in paediatric patients with T2D in children aged ten years and older, based on positive results from the paediatric T2NOW Phase III trial
  • What is the recommended first-line therapy for a typical . . .
    Metformin is the mandatory first-line pharmacologic therapy for adults with type 2 diabetes, combined with lifestyle modifications (diet and exercise), unles
  • KERENDIA® (finerenone): A Treatment Option for Adults With . . .
    KERENDIA® (finerenone): A Treatment Option for Adults With CKD Associated With T2D Please see the KERENDIA® Indication and Important Safety Information provided throughout the slide deck, and the accompanying Prescribing Information





中文字典-英文字典  2005-2009